Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
2016 ◽
Vol 9
(5)
◽
pp. 419-430
◽
Keyword(s):
Keyword(s):
Keyword(s):